Department of Medical Microbiology, Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Wilrijk, Belgium.
These authors contributed equally to this work and share first authorship.
Euro Surveill. 2020 Jul;25(27). doi: 10.2807/1560-7917.ES.2020.25.27.2001223.
Laboratory preparedness with quality-assured diagnostic assays is essential for controlling the current coronavirus disease (COVID-19) outbreak. We conducted an external quality assessment study with inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) samples to support clinical laboratories with a proficiency testing option for molecular assays. To analyse SARS-CoV-2 testing performance, we used an online questionnaire developed for the European Union project RECOVER to assess molecular testing capacities in clinical diagnostic laboratories.
实验室应准备经质量保证的诊断检测,这对于控制当前的冠状病毒病(COVID-19)疫情至关重要。我们使用灭活的严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)样本进行了一项外部质量评估研究,为临床实验室提供了分子检测能力的能力验证选项。为了分析 SARS-CoV-2 检测性能,我们使用了欧盟项目 RECOVER 开发的在线问卷来评估临床诊断实验室的分子检测能力。